{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T12:54:46Z","timestamp":1782824086059,"version":"3.54.5"},"reference-count":39,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T00:00:00Z","timestamp":1554336000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007155","name":"Medical Research Council Canada","doi-asserted-by":"publisher","award":["MR\/N00633X\/1"],"award-info":[{"award-number":["MR\/N00633X\/1"]}],"id":[{"id":"10.13039\/501100007155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007155","name":"Medical Research Council Canada","doi-asserted-by":"publisher","award":["MR\/N00633X\/1"],"award-info":[{"award-number":["MR\/N00633X\/1"]}],"id":[{"id":"10.13039\/501100007155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dom-pubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To describe population\u2010level time trends in prescribing patterns of type 2 diabetes therapy, and in short\u2010term clinical outcomes (glycated haemoglobin [HbA1c], weight, blood pressure, hypoglycaemia and treatment discontinuation) after initiating new therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>We studied 81\u2009532 people with type 2 diabetes initiating a first\u2010 to fourth\u2010line drug in primary care between 2010 and 2017 inclusive in United Kingdom electronic health records (Clinical Practice Research Datalink). Trends in new prescriptions and subsequent 6\u2010 and 12\u2010month adjusted changes in glycaemic response (reduction in HbA1c), weight, blood pressure and rates of hypoglycaemia and treatment discontinuation were examined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Use of dipeptidyl peptidase\u20104 inhibitors as second\u2010line therapy near doubled (41% of new prescriptions in 2017 vs. 22% in 2010), replacing sulphonylureas as the most common second\u2010line drug (29% in 2017 vs. 53% in 2010). Sodium\u2010glucose co\u2010transporter\u20102 inhibitors, introduced in 2013, comprised 17% of new first\u2010 to fourth\u2010line prescriptions by 2017. First\u2010line use of metformin remained stable (91% of new prescriptions in 2017 vs. 91% in 2010). Over the study period there was little change in average glycaemic response and in the proportion of people discontinuing treatment. There was a modest reduction in weight after initiating second\u2010 and third\u2010line therapy (improvement in weight change 2017 vs. 2010 for second\u2010line therapy: \u22121.5 kg, 95% confidence interval [CI] \u22121.9, \u22121.1;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), and a slight reduction in systolic blood pressure after initiating first\u2010, second\u2010 and third\u2010line therapy (improvement in systolic blood pressure change 2017 vs. 2010 range: \u22121.7 to \u22122.1 mmHg; all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). Hypoglycaemia rates decreased over time with second\u2010line therapy (incidence rate ratio 0.94 per year, 95% CI 0.88, 1.00;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.04), mirroring the decline in use of sulphonylureas.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Recent changes in prescribing of therapy for people with type 2 diabetes have not led to a change in glycaemic response and have resulted in modest improvements in other population\u2010level short\u2010term clinical outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/dom.13687","type":"journal-article","created":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T02:14:47Z","timestamp":1551665687000},"page":"1576-1584","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: A retrospective analysis of primary care data, 2010\u20132017"],"prefix":"10.1111","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7171-732X","authenticated-orcid":false,"given":"John M.","family":"Dennis","sequence":"first","affiliation":[{"name":"Health Statistics Group Institute of Health Research, University of Exeter Medical School  Exeter UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Henley","sequence":"additional","affiliation":[{"name":"Health Statistics Group Institute of Health Research, University of Exeter Medical School  Exeter UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"McGovern","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Science Royal Devon and Exeter Hospital  Exeter UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Farmer","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences University of Oxford  Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular and Medical Sciences University of Glasgow  Glasgow UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1256-874X","authenticated-orcid":false,"given":"Rury R.","family":"Holman","sequence":"additional","affiliation":[{"name":"Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism University of Oxford  Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewan R.","family":"Pearson","sequence":"additional","affiliation":[{"name":"Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School University of Dundee  Dundee UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T.","family":"Hattersley","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Science Royal Devon and Exeter Hospital  Exeter UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverley M.","family":"Shields","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Science Royal Devon and Exeter Hospital  Exeter UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0883-7599","authenticated-orcid":false,"given":"Angus G.","family":"Jones","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Science Royal Devon and Exeter Hospital  Exeter UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the MASTERMIND consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,4,4]]},"reference":[{"key":"e_1_2_8_2_1","unstructured":"National Institute for Health and Care Excellence. Type 2 diabetes in adults: management. NICE guideline (NG28).https:\/\/www.nice.org.uk\/guidance\/NG28. Published2015. Accessed May 15 2018."},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-S011"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.7326\/M16-1860"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.2337\/dci18-0033"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1414"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13346"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-022768"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/edm2.36"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.9400"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-018-1085-8"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13067"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-0985"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv098"},{"key":"e_1_2_8_15_1","unstructured":"Clinical Practice Research Datalink. Clinical Practice Research Datalink Bibliography.https:\/\/www.cprd.com\/Bibliography\/. Accessed May 15 2018."},{"key":"e_1_2_8_16_1","unstructured":"Joint Formulary Committee"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-017989"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2013-132068"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4518-6"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-0920"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/1536867X1201200209"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60691-6"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60683-2"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa066224"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504720"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.004007"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2015.07.015"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000000782"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-2680"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-016-4054-9"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12964"},{"key":"e_1_2_8_32_1","unstructured":"NHS Digital. Prescribing for Diabetes England \u2010 2006\/07 to 2016\/17.http:\/\/digital.nhs.uk\/catalogue\/PUB30043. Published August 1 2017. Accessed May 15 2018."},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i3625"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13083"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2012.03657.x"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1827"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-0344"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1603827"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611925"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.3024"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdom.13687","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dom.13687","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dom.13687","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/pdf\/10.1111\/dom.13687","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T04:49:23Z","timestamp":1761886163000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/10.1111\/dom.13687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,4]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["10.1111\/dom.13687"],"URL":"https:\/\/doi.org\/10.1111\/dom.13687","archive":["Portico"],"relation":{},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"value":"1462-8902","type":"print"},{"value":"1463-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,4]]},"assertion":[{"value":"2018-12-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}